Trial watch: Tumor-targeting monoclonal antibodies for oncological indications

An expanding panel of monoclonal antibodies (mAbs) that specifically target malignant cells or intercept trophic factors delivered by the tumor stroma is now available for cancer therapy. These mAbs can exert direct antiproliferative/cytotoxic effects as they inhibit pro-survival signal transduction...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncoimmunology
Egile Nagusiak: Vacchelli, Erika, Pol, Jonathan, Bloy, Norma, Eggermont, Alexander, Cremer, Isabelle, Fridman, Wolf Hervé, Galon, Jérôme, Marabelle, Aurélien, Kohrt, Holbrook, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2015
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4368132/
https://ncbi.nlm.nih.gov/pubmed/25949870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/2162402X.2014.985940
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak